Exane Derivatives Corbus Pharmaceuticals Holdings, Inc. Transaction History

Exane Derivatives

$157 Million
Q2 2022

A detailed history of Exane Derivatives transactions in Corbus Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Exane Derivatives holds 2,650 shares of CRBP stock, worth $140,344. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,650

Previous 4,766 44.4%

Holding current value

$140,344

Previous $2,000 100.0%

% of portfolio

0.0%

Previous 0.0%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$0.21 - $0.53 $444 - $1,121	-2,116 Reduced 44.4%	2,650 $0
Q4 2019 Jan 22, 2020	SELL	$4.29 - $5.64 $111,308 - $146,335	-25,946 Reduced 84.48%	4,766 $26,000
Q3 2019 Oct 15, 2019	SELL	$4.87 - $7.08 $23,327 - $33,913	-4,790 Reduced 13.49%	30,712 $149,000
Q2 2019 Jul 12, 2019	BUY	$6.6 - $7.8 $234,313 - $276,915	35,502 New	35,502 $0

Others Institutions Holding CRBP

# of Institutions

Shares Held

38.7K

Call Options Held

Put Options Held

View Full List

About Corbus Pharmaceuticals Holdings, Inc.

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $6.63B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

More about CRBP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Account

Exane Derivatives Corbus Pharmaceuticals Holdings, Inc. Transaction History